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Abstract
Introduction
Multimorbidity is a complex and growing health challenge. There is no accepted “gold standard”
multimorbidity measure for hospital resource planning, and few studies have compared measures in
hospitalised patients.
Aim
To evaluate operationalisation of two multimorbidity measures in routine hospital episode data in
NHS Grampian, Scotland.
Methods
Linked hospital episode data (Scottish Morbidity Record (SMR)) for the years 2009-2016 were used.
Adults admitted to hospital as a general/acute inpatient during 2014 were included. Conditions
(ICD-10) were identified from general/acute (SMR01) and psychiatric (SMR04) admissions during
the five years prior to first admission in 2014. Two count-based multimorbidity measures were used
(Charlson Comorbidity Index and Tonelli et al.), and multimorbidity was defined as ≥2 conditions.
Kappa statistics assessed agreement. The association between multimorbidity and length of stay,
readmission and mortality was assessed using logistic and negative binomial regression as appropriate.
Results
In 41,545 adults (median age 62 years, 52.6% female), multimorbidity prevalence was 15.1% (95% CI
14.8%, 15.5%) using Charlson and 27.4% (27.0%, 27.8%) using Tonelli – agreement 85.1% (Kappa
0.57). Multimorbidity prevalence, using both measures, increased with age. Multimorbidity was
higher in males (16.5%) than females (13.9%) using the Charlson measure, but similar across genders
when measured with Tonelli. After adjusting for covariates, multimorbidity remained associated
with longer length of stay (Charlson IRR 1.1 (1.0, 1.2); Tonelli IRR 1.1 (1.0, 1.2)) and readmission
(Charlson OR 2.1 (1.9, 2.2); Tonelli OR 2.1 (2.0, 2.2)). Multimorbidity had a stronger association
with mortality when measured using Charlson (OR 2.7 (2.5, 2.9)), than using Tonelli (OR 1.8 (1.7,
2.0)).
Conclusions
Multimorbidity measures operationalised in hospital episode data identified those at risk of poor
outcomes and such operationalised tools will be useful for future multimorbidity research and use in
secondary care data systems. Multimorbidity measures are not interchangeable, and the choice of
measure should depend on the purpose.
Highlights
• Operationalisation of two count-based multimorbidity measures using linked electronic hospital
episode data was evaluated (Charlson and Tonelli).
• First study to compare the Tonelli measure with another measure for investigating multimor-
bidity in hospitalised patients.
• Multimorbidity prevalence differed depending on measure used, but both multimorbidity mea-
sures identified those at risk of poor outcomes.
• Operationalised multimorbidity tools have uses for future multimorbidity research and use in
secondary care data systems.
• Multimorbidity measures are not interchangeable, and choice of measure should depend on
purpose.
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Introduction
Multimorbidity is the coexistence of multiple conditions, usu-
ally defined as two or more, in the same individual[1]. Along-
side an ageing population, multimorbidity is a growing public
health concern and a key research priority at an international
policy level[2-5]. Multimorbidity is associated with poor health
outcomes, high health service utilisation, and high health care
costs[6-10].
In addition to the importance of multimorbid-
ity/comorbidity measures in risk adjustment to reduce con-
founding, operational multimorbidity measures/tools are vital
for several reasons. In hospitalised populations, estimates of
the prevalence of multimorbidity are necessary to assess the
impact of multimorbidity on resources. Multimorbidity tools
are needed to identify patients at risk of poor outcomes at
point of admission, thus enabling more effective care, dis-
charge planning and improved outcomes. Identifying individ-
uals with multimorbidity has been highlighted as important in
international goals, policy[2-4] and national guidelines[11].
The prevalence of multimorbidity in hospitalised patients
varies widely among studies (22% to 99.7%)[12-17]. Some
of this difference is likely to be due to different methods
used for measuring multimorbidity including how multimor-
bidity is defined, the number and type of conditions included,
data sources and coding schemes, population studied, and set-
ting[18]. Multimorbidity is complex to measure and currently
there is no universal “gold standard”[1]. Numerous heteroge-
neous measures exist[1,18-20], falling into two broad types.
First, weighted indices, of which the most commonly used is
the Charlson Comorbidity Index[21]. Second, and more com-
monly used in multimorbidity studies[19], simple counts of
conditions or diagnostic categories, which utilize a selected list
of conditions or diagnostic categories, or all conditions within
a population. More recently, a simple count of the Charlson
Comorbidity Index conditions has been used in multimorbid-
ity research[15,22,23]. A count-based multimorbidity measure
published in a “landmark” study by Barnett et al.[24], identi-
fied 40 chronic conditions for measuring multimorbidity in a
primary care population from clinical coding and prescribing
data, using data coding unique to the UK (Read codes). This
study has been widely cited and many studies have reported us-
ing this measure[25-28]. Subsequently, a corresponding coding
scheme for use with administrative data based on the Interna-
tional Classification of Diseases (ICD) system was developed
by Tonelli et al.[29].
Several studies have directly compared weighted multi-
morbidity measures or compared weighted with simple count
measures[30-36]. Studies have also directly compared sim-
ple count-based multimorbidity measures in primary care and
general populations, reporting prevalence, emergency admis-
sion, functional decline, and physical quality of life[22,37,38].
We are aware of only two studies, however, that have directly
compared any simple count-based measures in hospitalised pa-
tients[15,23]. Dattalo et al.[23] compared four count-based
measures based on ICD coding, but focussed on patients aged
65 years and older. Prevalence estimates varied depending
on measure, and there was an increased risk of 30-day read-
mission for patients with multimorbidity for each of the four
measures. Schneider et al.[15] compared three count-based
measures in a small study of medical inpatients aged 18 years
and over admitted from the emergency unit reporting that
prevalence estimates varied for the three measures. Although
multimorbidity measures have been extensively studied, rela-
tively little is known about count-based measures in general
hospitalised populations, particularly in younger patients. To
our knowledge, the Tonelli coding scheme has not been stud-
ied in a hospitalised population for assessing multimorbidity
prevalence or outcomes.
The aim of this study was to operationalise and apply two
count based measures of multimorbidity (Charlson[39] and
Tonelli[29]) to routine hospital episode data, in order to a)
compare prevalence; b) assess agreement, and c) compare the
association between multimorbidity and length of hospital stay,
hospital readmission and mortality.
Methods
Study design and setting
This study is reported as per RECORD guidelines[40]. This
was a population-based observational study using linked elec-
tronic health records carried out in a secondary care setting in
a single health region in the north-east of Scotland (Grampian
region, total population 2014, 584,220[41]). An overview of
the study design is shown in Figure 1.
Data sources
We used hospital episode data, Scottish Morbidity Record
(SMR)[42], from general/acute (SMR01) and psychiatric
(SMR04) admissions, from the years 2009-2016. SMR is an
episode-based patient record relating to all patients discharged
from hospital in Scotland. A record is generated when a pa-
tient completes an episode of care (period of time spent under
the care of one consultant). These episodes are then linked
to form a continuous inpatient stay (CIS) representing one
admission, which may include transfers between consultants,
specialties and/or hospitals. SMR data is collated in a national
database, managed by Information Services Division Scotland
(ISD)[43], and data is returned to each regional health au-
thority on an ongoing basis. Data collected include patient
identifiable and demographic details, episode management de-
tails, general clinical information and death data. Clinical in-
formation is recorded as main diagnosis and up to five other
significant diagnoses, and coded using ICD-10. Deprivation
information was collected from the Scottish Index of Multiple
Deprivation (SIMD)[44], and rurality from the Scottish Gov-
ernment Urban Rural Classification system[45].
Study population
We included all adult patients (≥18 years) admitted to hos-
pital as an inpatient during 2014 (SMR01 only), for a single
regional health authority (NHS Grampian). We excluded day
case, obstetric and psychiatric admissions when identifying the
index admission. A patient’s first admission in 2014 was clas-
sified as their “index admission”, and the admission date was
classified as their “index date”. The flow diagram for identify-
ing the study population is shown in Figure 2. From index date
in 2014, follow-up data were available to 31 October 2016.
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Multimorbidity
Multimorbidity was defined a priori as ≥2 conditions[1,11],
measured using an unweighted simple count of conditions.
Conditions were identified from general/acute (SMR01, in-
cluding day cases) and psychiatric (SMR04) admissions in the
five years prior to index date, recorded as either main or other
diagnosis. We compared two measures. The first was a count
of the 17 conditions included in the Charlson Comorbidity In-
dex, based on ICD-10 coding[39] (Charlson measure). The
second measure was a count of the 30 chronic conditions de-
veloped by Tonelli et al.[29], based on ICD-10 coding (Tonelli
measure). For each measure, multiple pre-specified ICD-10
codes were used to define each condition. Twelve conditions
were common to both the Charlson and Tonelli measures.
However, only dementia, rheumatic disease and metastatic
cancer had identical ICD-10 codes for both measures. While
the Charlson measure included hemiplegia or paraplegia and
AIDS, these conditions were not included in the Tonelli mea-
sure. The Tonelli measure on the other hand, included many
conditions not included in the Charlson measure: hyperten-
sion, alcohol misuse, atrial fibrillation and flutter, chronic pain,
depression, epilepsy, hypothyroidism, inflammatory bowel dis-
ease, irritable bowel syndrome, multiple sclerosis, Parkinson’s
disease, psoriasis, schizophrenia, and severe constipation. The
specific ICD-10 codes for conditions included in each measure
are detailed in Supplementary Appendix 1, with a note of mi-
nor amendments made to the Tonelli measure. These codes
were translated into computerised algorithms and applied to
SMR data to identify the conditions of interest. For data qual-
ity purposes, a validation dataset containing all ICD-10 codes
for main and other diagnoses recorded in the five years prior
to index date for a random sample of 50 patients was manu-
ally checked against the final dataset. This showed that the
computerized algorithms correctly captured conditions for all
patients in the sample.
Other covariates
Other baseline characteristics were sex, age, deprivation, ru-
rality, and admission type (routine or emergency). Age was
categorised into six age groups. Deprivation was measured
using SIMD quintiles[44], and rurality was measured using the
Scottish Government 6 fold Urban Rural Classification[45].
Outcomes
Study outcomes were multimorbidity prevalence, length of stay
of index admission, calculated as the number of days from ad-
mission date until discharge date of the whole CIS (discharged
alive or dead), hospital readmission (whole CIS, including gen-
eral/acute inpatient and day case admissions, excluding psy-
chiatric and obstetric admissions) up to one year from dis-
charge date and all-cause mortality up to one year from index
date.
Data linkage
NHS Grampian SMR data were held in a dedicated secure
server, managed by the accredited Grampian Data Safe Haven
(DaSH)[46]. The Community Health Index (CHI) number, a
unique patient identifier used throughout the Scottish health
care system, was used to link the study population to hospital
episode and death data, using deterministic matching. Post-
codes were used to link the study population to SIMD and
Urban Rural Classification. The de-identified dataset was pre-
pared and hosted by the Grampian DaSH[46], allowing secure
controlled access for researchers while ensuring data security.
There were 662 admissions in 2014 (inpatient gen-
eral/acute, ≥18 years) with missing CHI numbers, therefore
these were not included in our study population. There were
314 patients who could not be linked with SIMD, and 576 pa-
tients who could not be linked with Urban Rural Classification,
because of postcode issues (Figure 2). The characteristics of
patients with missing values are reported in Supplementary
Appendix 2.
Statistical analysis
Baseline characteristics were described as frequencies and per-
centages or as median and interquartile range (IQR). We cal-
culated the prevalence of multimorbidity, and 95% confidence
intervals (CI), as the proportion of patients with ≥2 condi-
tions. Prevalence was reported by age group, sex, admission
type (routine or emergency), SIMD quintile and Urban Rural
category. Agreement between the two measures for classify-
ing patients as multimorbid was assessed using the Kappa-
statistic, by sex and age group (<75/≥75 years). We cate-
gorised Kappa scores as follows: κ ≤ 0.20 = poor, 0.21 ≤ κ
≤ 0.40 = fair, 0.41 ≤ κ ≤0.60 = moderate, 0.61 ≤ κ ≤ 0.80
= substantial, κ > 0.80 = good. To assess the association
between variables, we used a χ2 test, Wilcoxon rank sum and
Kruskal-Wallis test as appropriate. A complete case analysis of
the association between multimorbidity and length of stay was
assessed using multivariate negative binomial regression to es-
timate unadjusted and adjusted incident rate ratios (IRR) with
95% CI. The association between multimorbidity and readmis-
sion within one year of discharge date and mortality within
one year of index date was assessed using multivariate logis-
tic regression to estimate unadjusted and adjusted odds ratios
(OR). All models were adjusted for age, sex, admission type,
SIMD quintile and Urban Rural category. To assess model fit
for mortality and readmission, we computed pseudo R2 (Cox &
Snell/Nagelkerke). For length of stay we computed the Akaike
information criterion (AIC) and the Bayesian information cri-
terion (BIC). Analyses were performed using Stata v13.0 and
SPSS v24.
Ethical approval
The study was approved by the North of Scotland Research
Ethics Service (REC B Ref. 16/NI/0088), NHS Grampian
Research and Development (Ref. 2016UA006) and NHS
Grampian Caldicott Guardian.
Results
Baseline characteristics
There were 41,545 patients included with a median age of 62
years (IQR 44-75 years) and 52.6% were female (Table 1). The
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majority of patients were admitted as an emergency (69.3%).
Just over half of patients were from the two least deprived
quintiles (52.4%), and urban categories (52.7%); comparable
with the population distribution in the Grampian region. Ap-
proximately two-thirds (64.5%) of patients had been admitted
to hospital at least once in the five years prior to index date.
Prevalence of individual conditions
Of the individual conditions recorded in the five years prior
to index admission that contributed to the Charlson measure,
those with the highest prevalence were chronic pulmonary dis-
ease (11.3%), diabetes without complications (7.5%), malig-
nancy (6.9%), renal disease (6.1%) and myocardial infarction
(5.6%). The individual conditions with the highest prevalence
from the Tonelli measure were hypertension (19.0%), diabetes
(8.4%), chronic kidney disease (8.2%), asthma (6.7%) and
atrial fibrillation and flutter (6.1%) (Supplementary Appendix
1).
Prevalence of multimorbidity
Counts of conditions ranged from 0-7 for Charlson and 0-11
for Tonelli (Table 1). Sixty-six percent of the population had
0 conditions using Charlson, compared to 55.1% when using
Tonelli (Table 1). The proportion of patients with multimor-
bidity (≥2 conditions) for each measure is presented in Table
1. Overall, the prevalence of multimorbidity was lower when
measured using Charlson compared to Tonelli (overall 15.1%
vs 27.4% respectively).
The proportion of patients with multimorbidity increased
with age (Table 1). Figure 3 shows the prevalence of mul-
timorbidity by gender, for different age groups. At younger
ages (<60 years), females had similar or very slightly higher
prevalence of multimorbidity than males using both measures,
whereas at older ages (≥60 years), this seemed to reverse and
males had a slightly higher prevalence of multimorbidity than
females. However, overall, the prevalence of multimorbidity
was higher in males than females when measured using Charl-
son (16.5% and 13.9% respectively; p<0.001), but similar for
males and females when measured using Tonelli (27.1% and
27.7% respectively) (Table 1).
Agreement between multimorbidity measures
in classifying patients as multimorbid
Overall, 85.1% of the study population was consistently
classified by Charlson and Tonelli as either multimorbid or
not, showing moderate agreement between the two measures
(Kappa 0.57) (Table 2). Agreement was slightly higher for
males (agreement 86.1%, Kappa 0.60) compared to females
(agreement 84.3%, Kappa 0.54). Agreement was higher for
patients <75 years (agreement 87.8%, Kappa 0.54) compared
to ≥75 years (agreement 77.9%, Kappa 0.54).
Outcomes
All patients had been discharged (alive or dead) by the end
of follow-up (31 October 2016). The overall median length
of stay was 2 days (IQR 1-6). Length of stay was longer for
patients with multimorbidity compared to those with <2 con-
ditions (Charlson adjusted IRR 1.1 (95% CI 1.0, 1.2); Tonelli
adjusted IRR 1.1 (95% CI 1.0, 1.2)) (Table 3).
A total of 18,318 patients (45.6% of patients discharged
alive) were readmitted at least once within one year of dis-
charge date. Patients with multimorbidity had a higher risk of
readmission compared to those with <2 conditions (Charlson
adjusted OR 2.1 (95% CI 1.9, 2.2); Tonelli adjusted OR 2.1
(95% CI 2.0, 2.2) (Table 3).
A total of 4,619 (11.1%) patients died within one year of
index date. Of these 1,403 died during index admission and
3,216 died following index admission but within one year of
index date. Patients with multimorbidity had a higher risk of
death compared to those with <2 conditions (Charlson ad-
justed OR 2.7 (95% CI 2.5, 2.9); Tonelli adjusted OR (95%
CI 1.8 (1.7, 2.0)) (Table 3).
Discussion
In our study of hospital patients, we found that the prevalence
of multimorbidity was higher when measured using Tonelli,
compared with Charlson. Both measures found that multimor-
bidity increased with age, but there were differences between
the measures for gender, with a higher prevalence of multi-
morbidity in males than females using Charlson, but similar for
males and females when using Tonelli. There was moderate
agreement between the two measures in classifying patients
as multimorbid or not, with more agreement evident in males
and younger patients. Multimorbidity, measured using both
Tonelli and Charlson, was associated with an increased risk
of longer length of stay, readmission and mortality. To our
knowledge, this is the first study to compare the Tonelli mea-
sure with another multimorbidity measure, in a hospitalised
adult population.
We found moderate agreement between Tonelli and Charl-
son when classifying patients as multimorbid, and that the
overall prevalence of multimorbidity was higher when mea-
sured using Tonelli (27.4%) compared to Charlson (15.1%).
Our finding of a higher prevalence using Tonelli, which in-
cludes a larger number of conditions than Charlson, was not
unexpected, and is consistent with other studies in primary
care[18,22,37,38] and hospitalised patients[15].
Although several studies have compared weighted
measures[33-36], to our knowledge only two previous studies
compared count-based multimorbidity measures in hospitalised
patients[15,23]. Neither of these studies used the Tonelli mea-
sure (based on the landmark Barnett study[24]), although both
included a count of Charlson conditions. Dattalo et al.[23]
compared four count-based measures in patients aged 65 and
older, based on ICD coding. Comparing Charlson to the other
three measures, they reported Kappa values of 0.07, 0.36 and
0.44 – lower agreement than we found when comparing Charl-
son with Tonelli (Kappa 0.57). They also reported a wide
variation in the prevalence of multimorbidity between measures
(18.6% to 92.9%). Prevalence did not seem to increase with
the number of conditions included, but there were method-
ological differences in how the measures were operationalised
which may explain this. Using the Charlson measure, Dat-
talo et al.[23] reported a multimorbidity prevalence of 36.8%,
which was higher than we found in patients of a similar age
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(≥60 years, 23.8%). However, we used only inpatient admis-
sion data, whereas Dattalo et al.[23] included inpatient and
outpatient data to identify Charlson conditions[23]. The other
study by Schneider et al.[15] compared three count-based mea-
sures, reporting a multimorbidity prevalence of 48.2% for the
Charlson measure, considerably higher than we have reported.
However, this was a small study of medical inpatients admit-
ted from the emergency unit, which may represent a patient
population with a high severity of illness[15].
We found that the prevalence of multimorbidity increased
with age, for both measures, which is a well-recognised asso-
ciation. Although multimorbidity increased with age, we still
found substantial multimorbidity in younger age groups, par-
ticularly using Tonelli, as shown in Table 1. The prevalence of
multimorbidity was higher in males than females when mea-
sured using Charlson, but similar for males and females when
using Tonelli. This finding is not consistent with previous re-
ports in primary care populations, where multimorbidity is gen-
erally more common in females[6,12,24]. Studies reporting the
prevalence of multimorbidity by gender in hospitalised popu-
lations are limited, and report conflicting results[14,16,47,48].
We also noted some evidence of a different pattern of multi-
morbidity between males and females at different age groups.
Any age and sex differences are likely to be a reflection of the
specific conditions included in the two measures. The majority
of conditions included in the Charlson measure may be more
prevalent in older individuals and males, whereas the Tonelli
measure includes conditions that may be more common in
younger individuals (for example, asthma, epilepsy, psoriasis),
and females (for example, chronic pain, depression, hypothy-
roidism).
Multimorbidity, measured using both Charlson and Tonelli,
was associated with an increased risk of longer length of stay,
readmission, and mortality. Length of stay and readmission
risk was similar for both measures. There was a stronger asso-
ciation between multimorbidity and mortality when measured
using Charlson, compared with Tonelli, but the model fit was
similar. This finding was not unexpected given that Charl-
son was developed to predict mortality[21], and includes many
drivers of all-cause mortality, whereas there were more in num-
ber but relatively less mortal conditions included in Tonelli.
Dattalo et al.[23] reported an increased risk of 30-day read-
mission for patients aged 65 and older with multimorbidity,
for each of the four measures they assessed, reporting ORs
ranging from 1.1 to 1.5, and that Charlson and Medicare Ad-
vantage Chronic Condition Special Needs Plan were the best
predictors of 30-day readmission.
This was a large, population-based study, not limited to
an age or patient group. We ascertained conditions over
the five years prior to index date, as longer lookback peri-
ods have been shown to be better at identifying patients with
chronic conditions[49-51]. We used high quality administrative
data[52], and undertook quality assurance assessments to en-
sure accuracy of coding algorithms. We used two high profile
measures: Tonelli et al.[29], based on the landmark Barnett et
al. study[24], as well as the widely used Charlson measure[39].
Furthermore, to our knowledge, this is the first study to use
the Tonelli measure for investigating multimorbidity in hos-
pitalised patients, and first to compare Tonelli with another
measure.
Limitations, however, should be recognised. Conditions
were identified from hospital episode data in the five years
prior to admission in 2014, and 35.5% of our population had
no admission in the previous five years. As a result, we will
not have recorded conditions for patients who were first time
presenters, and will have underestimated the multimorbidity
burden in our population, especially for conditions that do not
lead to hospitalisation or which are not a priority for record-
ing on discharge records. This situation is likely to have more
effect on the Tonelli conditions than the Charlson conditions.
However, as hospital episode data may be the only information
available to clinicians when a patient is admitted, we feel that
using this methodology is relevant and important to examine.
This also highlights the importance of an integrated primary
and secondary care patient record, which would provide more
information to clinicians and a fuller picture of multimorbidity.
We could not explore differences in multimorbidity by ethnicity,
as the Grampian population is ethnically homogeneous with
only ∼4% of the population non-White ethnic minorities[53].
We have used simple counts of conditions and as such have
applied uniform weights to all conditions and therefore take
no account of severity of illness. Weighted measures should
be used where they are validated for a particular outcome of
interest. However, where there are multiple outcomes being
considered in a study, the use of disease counts is more appro-
priate[19,24,54]. Thus, the approach in our study is reasonable
but we also acknowledge that our conclusions are only valid in
the context of using simple count-based measures. Finally, we
compared only two measures of multimorbidity, acknowledg-
ing that many measures exist. Both measures were selected
on the basis of their high profile nature. Charlson was included
as it is a widely adopted validated measure[19]. Tonelli was
included as it was an adaptation of the landmark study by
Barnett et al.[24] Tonelli addressed the requirement for ICD
coding algorithms for the Barnett conditions.
It should also be highlighted, that the study by Tonelli et
al.[29] did not identify appropriate algorithms for all 40 con-
ditions included in the Barnett et al.[24] measure. There were
also some differences in the specific conditions included in the
measure (Supplementary Appendix 3). In order to fully imple-
ment the Barnett measure, ICD coding algorithms for all the
conditions would be valuable.
The methodology used in our study with regard to either
measure of multimorbidity would be applicable to health sys-
tems worldwide that use the ICD-10 coding system. The find-
ings for the prevalence and outcomes of multimorbidity would
likely apply to other hospitalised populations with similar char-
acteristics to our study population.
Information on the prevalence and outcomes of multimor-
bidity in hospitalised patients is essential for service planning,
clinical decision-making and clinical research. At point of ad-
mission, assessment may benefit from the inclusion of a multi-
morbidity tool to identify high risk patients, and to plan patient
care. Our findings have implications for the choice of measure.
For investigating the burden of multimorbidity, it may be more
useful to use a more comprehensive measure which includes a
large number of conditions, such as Barnett et al.[24] or Tonelli
et al.[29], facilitating comparison with other studies using sim-
ilar measures. For identifying high risk patients, it makes little
difference which measure is used, at least for the outcomes
investigated in our study. Charlson, however, is less data in-
tensive and more strongly associated with mortality. We have
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demonstrated the potential of linking electronic health records
to identify hospitalised patients at risk of worse outcomes for
assessment and targeted intervention. An integrated primary
and secondary care patient record would provide more infor-
mation to clinicians at point of admission.
Conclusion
Multimorbidity measures operationalised in electronic hospital
episode data identified those at risk of poor outcomes and such
operationalised tools will be useful for future multimorbidity
research and use in secondary care data systems, for example
to assess multimorbidity at point of admission in order to in-
form patient management and ongoing care. Multimorbidity
measures are not interchangeable, and choice of measure will
depend on purpose.
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Figure 1: Overview of study design
Study year
2014 
Data: 
1 Jan 2009 31 Oct 2016
Analysis:
Identify conditions 
from admissions 
during 5 years prior 
to index admission
(SMR01 and SMR04)
All adults admitted 
as inpatient during 
2014 (SMR01)
First admission = 
index admission
Assess mortality 
and readmission 
over 1 year follow-
up from index 
admission
SMR, Scottish Morbidity Record (SMR01 general/acute, SMR04 psychiatric)
Figure 2: Flowchart of study population and data linkage
SMR, Scottish Morbidity Record; SIMD, Scottish Index of Multiple Deprivation aCHI number was missing or invalid for 662
inpatient general/acute admissions in 2014 (patients ≥18 years), therefore not included in the study population.
10
Robertson, L et. al. / International Journal of Population Data Science (2019) 4:1:02
Table 1: Baseline characteristics and prevalence of multimorbidity by two measures
Total Charlson ≥2 conditions Tonelli ≥2 conditions
n (%) % (95% CI) % (95% CI)
All patients 41,545 15.1% (14.8-15.5) 27.4% (27.0-27.8)
Sex
Male 19,677 (47.4%) 16.5% (16.0-17.0) 27.1% (26.4-27.7)
Female 21,868 (52.6%) 13.9% (13.5-14.4) 27.7% (27.1-28.3)
Age groups
18-29 4,677 (11.3%) 1.1% (0.8-1.4) 5.9% (5.3-6.6)
30-44 5,932 (14.3%) 3.7% (3.2-4.2) 11.0% (10.3-11.9)
45-59 8,671 (20.9%) 8.4% (7.8-9.0) 19.0% (18.2-19.8)
60-74 11,160 (26.9%) 19.3% (18.6-20.1) 32.8% (31.9-33.7)
75-89 9,705 (23.4%) 28.3% (27.4-29.2) 45.8% (44.8-46.8)
≥90 1,400 (3.4%) 28.0% (25.7-30.4) 50.1% (47.5-52.8)
Admission type
Routine 12,754 (30.7%) 11.3% (10.7-11.8) 22.6% (21.9-23.4)
Emergency 28,791 (69.3%) 16.9% (16.4-17.3) 29.5% (29.0-30.1)
SIMD 2012a
1 (most deprived) 3,317 (8.0%) 15.2% (14.0-16.5) 28.7% (27.2-30.3)
2 6,279 (15.1%) 16.3% (15.4-17.2) 29.2% (28.1-30.4)
3 9,886 (23.8%) 15.8% (15.1-16.5) 28.7% (27.8-29.6)
4 10,792 (26.0%) 15.0% (14.3-15.7) 26.6% (25.8-27.5)
5 (least deprived) 10,957 (26.4%) 14.3% (13.6-14.9) 26.0% (25.2-26.9)
Urban Rurala
Large urban 15,577 (37.5%) 15.8% (15.2-16.3) 28.8% (28.1-29.5)
Other urban 6,329 (15.2%) 16.1% (15.2-17.0) 29.1% (28.0-30.2)
Accessible small town 3,329 (8.0%) 16.6% (15.3-17.9) 27.8% (26.3-29.3)
Remote small town 3,719 (9.0%) 15.5% (14.4-16.7) 28.3% (26.9-29.8)
Accessible rural 7,484 (18.0%) 14.7% (13.9-15.5) 26.7% (25.7-27.7)
Remote rural 4,531 (10.9%) 12.0% (11.1-13.0) 22.0% (20.9-23.3)
Admitted in previous 5 years
Yes 26,780 (64.5%)
No 14,765 (35.5%)
Number of Charlson conditions
0 27,560 (66.3%) - - - -
1 7,697 (18.5%) - - - -
2 3,867 (9.3%) - - - -
3 1,578 (3.8%) - - - -
4 578 (1.4%) - - - -
5 195 (0.5%) - - - -
6 61 (0.1%) - - - -
7 9 (0.0%) - - - -
Number of Tonelli conditions
0 22,884 (55.1%) - - - -
1 7,272 (17.5%) - - - -
2 5,173 (12.5%) - - - -
3 3,241 (7.8%) - - - -
4 1,665 (4.0%) - - - -
5 783 (1.9%) - - - -
6 357 (0.9%) - - - -
7 100 (0.2%) - - - -
8 56 (0.1%) - - - -
9 9 (0.0%) - - - -
10+ 5 (0.0%) - - - -
Length of stay, days (median, IQR) 2 (1-6) 3 (1-8) 3 (1-8)
Readmission within 1 year of discharge, n (%) 18,318 (44.1%) 3,976 (63.2%) 6,861 (60.2%)
Died within 1 year of index date, n (%) 4,619 (11.1%) 1,860 (29.6%) 2,431 (21.3%)
CI, confidence interval; SIMD, Scottish Index of Multiple Deprivation; IQR, interquartile range. a 314 patients had missing values
for SIMD category and 576 patients had missing values for Urban Rural category.
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Figure 3: Prevalence of multimorbidity by age and sex
Percent with ≥2 Charlson conditions
18-29 30-44 45-59 60-74* 75-89* ≥90*
Male 1.0% 3.2% 8.3% 21.0% 32.2% 31.5%
Female 1.1% 4.1% 8.5% 17.6% 25.0% 26.2%
Percent with ≥2 Tonelli conditions
18-29 30-44* 45-59* 60-74 75-89 ≥90
Male 5.8% 9.3% 17.5% 33.0% 46.5% 51.5%
Female 6.0% 12.5% 20.5% 32.6% 45.3% 49.5%
* difference between genders by age group p<0.05.
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Table 2: Agreement between Tonelli and Charlson
Group Total Agreement Discordant Agreement Kappa
Charlson <2 Charlson ≥2 Charlson <2 Charlson ≥2
Tonelli <2 Tonelli ≥2 Tonelli ≥2 Tonelli <2 %
n % n % n % n %
Total 41,545 29,620 (71.3) 5,752 (13.8) 5,637 (13.6) 536 (1.3) 85.14 0.57
Sex
Males 19,677 14,024 (71.3) 2,915 (14.8) 2,408 (12.2) 330 (1.7) 86.09 0.60
Females 21,868 15,596 (71.3) 2,837 (13.0) 3,229 (14.8) 206 (0.9) 84.29 0.54
Age group
Age <75 30,440 23,884 (78.5) 2,838 (9.3) 3,403 (11.2) 315 (1.0) 87.79 0.54
Age ≥75 11,105 5,736 (51.6) 2,914 (26.2) 2,234 (20.1) 221 (2.0) 77.89 0.54
Table 3: Association between multimorbidity and length of stay, readmission and mortality
Total Length of stay Readmitted 1 year from
discharge datea
Died 1 year from index
dateb
n median (IQR) adjusted IRR Number adjusted OR Number adjusted OR
(95% CI) readmitted (95% CI) died (95% CI)
Charlson
<2 conditions 35,257 2 (1-5) Reference 14,342 Reference 2,759 Reference
≥2 conditions 6,288 3 (1-8) 1.1 (1.0, 1.2)* 3,976 2.1 (1.9, 2.2)** 1,860 2.7 (2.5, 2.9)**
Tonelli
<2 conditions 30,156 2 (1-5) Reference 11,457 Reference 2,188 Reference
≥2 conditions 11,389 3 (1-8) 1.1 (1.0, 1.2)*** 6,861 2.1 (2.0, 2.2)** 2,431 1.8 (1.7, 2.0)**
IQR, interquartile range; IRR, incident rate ratio; OR, odds ratio; CI, confidence interval. a 9 patients did not have a full year of
follow-up data from discharge date to 31 October 2016, of whom 2 were readmitted, and 7 were not readmitted up to 31 October
2016.
b 1,403 patients died during index admission and 3,216 died following index admission but within 1 year of index date.
* p=0.005
** p<0.001
*** p=0.001
Notes:
All models adjusted for age, sex, type of admission (routine or emergency), SIMD quintile and Urban Rural category.
621 patients had missing values for SIMD and/or Urban Rural category, therefore not included in the adjusted models.
Model fit for Length of Stay: Charlson AIC 230767, BIC 230896; Tonelli AIC 230748, BIC 230877
Model fit for Readmission: Charlson Cox & Snell 0.039, Nagelkerke 0.053; Tonelli Cox & Snell 0.048, Nagelkerke 0.064
Model fit for Mortality: Charlson Cox & Snell 0.140, Nagelkerke 0.278; Tonelli Cox & Snell 0.132, Nagelkerke 0.261
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